970 results on '"Rammensee, Hans-Georg"'
Search Results
2. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
3. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
4. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
5. The HLA ligandome of oropharyngeal squamous cell carcinomas reveals shared tumour-exclusive peptides for semi-personalised vaccination
6. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
7. Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes
8. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
9. Radiotherapy planning parameters correlate with changes in the peripheral immune status of patients undergoing curative radiotherapy for localized prostate cancer
10. Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma* [S]
11. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
12. Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens
13. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
14. Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells
15. P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS
16. Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response
17. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
18. Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
19. Activated integrins identify functional antigen-specific CD8⁺ T cells within minutes after antigen stimulation
20. The immunopeptidomic landscape of ovarian carcinomas
21. Actively personalized vaccination trial for newly diagnosed glioblastoma
22. Personalized cancer vaccines: adjuvants are important, too
23. Glycoprotein 96-Activated Dendritic Cells Induce a CD8-Biased T Cell Response
24. Autophagy Promotes MHC Class II Presentation of Peptides from Intracellular Source Proteins
25. Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
26. Identification of Vaccinia Virus Epitope-Specific HLA-A* 0201-Restricted T Cells and Comparative Analysis of Smallpox Vaccines
27. Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft–host interaction
28. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
29. Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
30. "Electronic Nose" Detects Major Histocompatibility Complex-Dependent Prerenal and Postrenal Odor Components
31. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
32. The Heat Shock Protein gp96: A Receptor-Targeted Cross-Priming Carrier and Activator of Dendritic Cells
33. Cleavage Motifs of the Yeast 20S Proteasome β Subunits Deduced from Digests of Enolase 1
34. Staining of activated ß2-integrins in combination with CD137 and CD154 for sensitive identification of functional antigen-specific CD4+ and CD8+ T cells
35. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells
36. IMMU-28. THE INTRA-TUMORAL SPATIAL HETEROGENEITY OF T CELL ANTIGENS IN GLIOBLASTOMA: AN INTEGRATED MULTI-OMICS APPROACH
37. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy
38. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
39. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications
40. Simultaneous Identification of Functional Antigen-Specific CD8+ and CD4+ Cells after In Vitro Expansion Using Elongated Peptides
41. IgG-Based Bispecific Anti-CD95 Antibodies for the Treatment of B Cell-Derived Malignancies and Autoimmune Diseases
42. Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
43. 64 Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET
44. HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
45. Dipeptides catalyze rapid peptide exchange on MHC class I molecules
46. “Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015
47. Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during checkpoint blockade
48. Abstract CT258: Interim safety and immunogenicity results of a phase I trial evaluating the multi-peptide COVID-19 vaccine candidate CoVac-1 for induction of SARS-CoV-2 T cell immunity in cancer patients with disease- or treatment-related immunoglobulin deficiency
49. Abstract 3555: Immunopeptidomics-guided tumor antigen warehouse design for peptide-based immunotherapy in head and neck squamous cell carcinomas
50. Abstract 3168: Immunopeptidome-defined acute myeloid leukemia progenitor cell-associated antigens are targeted in vivo by AML patients’ T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.